WGS Q3 2022 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q3 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$83M+92.8% YoY

Gross Profit

$14M16.3% margin

Operating Income

-$91M-109.1% margin

Net Income

-$78M-93.2% margin

EPS (Diluted)

$-6.72

QoQ Revenue Growth

+130.1%

Cash Flow

Operating Cash Flow

-$88M

Free Cash Flow

-$93M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$829M

Total Liabilities

$268M

Stockholders' Equity

$561M

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$43M	+92.8%
Gross Profit	$14M	-$8M	+263.1%
Operating Income	-$91M	-$88M	-2.9%
Net Income	-$78M	$33M	-337.0%

Revenue Segments

Diagnostic Test

$81M49%

Diagnostic Test, Third Party Insurance

$64M39%

Diagnostic Test, Institutional Customers

$15M9%

Diagnostic Test, Self Pay

$2M1%

Product and Service, Other

$2M1%